The effects of prognostic factors on transplant and mortality of patients with end-stage liver disease using Markov multistate model

被引:0
|
作者
Madreseh, Elham [1 ,2 ]
Mahmoudi, Mahmood [1 ]
Toosi, Mohssen Nassiri [3 ]
Abolghasemi, Jamileh [4 ]
Zeraati, Hojjat [1 ]
机构
[1] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran
[2] Univ Tehran Med Sci, Rheumatol Res Ctr, Tehran, Iran
[3] Univ Tehran Med Sci, Liver Transplantat Res Ctr, Imam Khomeini Hosp Complex, Tehran, Iran
[4] Iran Univ Med Sci, Sch Publ Hlth, Dept Biostat, Tehran, Iran
来源
关键词
Cirrhosis; life expectancy; model for end-stage liver disease; survival; LONG-TERM SURVIVAL; WAITING-LIST; LIFE EXPECTANCY; MELD; RECIPIENTS; CIRRHOSIS; SCORE; BENEFIT; HEALTH; STATES;
D O I
10.4103/jrms.jrms_1091_21
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Decompensated cirrhosis patients have a high risk of death which can be considerably reduced with liver transplantation (LT). This study aimed to simultaneously investigate the effect of some patients' characteristics on mortality among those with/without LT and also LT incident.Materials and Methods: In this historical cohort study, the information from 780 eligible patients aged 18 years or older was analyzed by the Markov multistate model; they had been listed between 2008 and 2014, needed a single organ for initial orthotopic LT, and followed at least for up to 5 years.Results: With a median survival time of 6 (5-8) years, there were 275 (35%) deaths. From 255 (33%) patients who had LT, 55 (21%) subsequently died. Factors associated with a higher risk of mortality and LT occurrence were included: higher model for end-stage liver disease (MELD) score (hazard ratio [HR] = 1.16, confidence interval [CI]: 1.09-1.24 and HR = 1.22, CI: 1.41-1.30) and ascites complication (HR = 2.34, CI: 1.74-3.16 and HR = 11.43, CI: 8.64-15.12). Older age (HR = 1.03, CI: 1.01-1.06), higher creatinine (HR = 6.87, CI: 1.45-32.56), and autoimmune disease versus hepatitis (HR = 2.53, CI: 1.12-5.73) were associated with increased risk of mortality after LT.Conclusion: The MELD and ascites are influential factors on waiting list mortality and occurrence of LT. Total life expectancy is not influenced by higher MELD.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] A prognostic model for patients with end-stage liver disease
    Cooper, GS
    Bellamy, P
    Dawson, NV
    Desbiens, N
    Fulkerson, WJ
    Goldman, L
    Quinn, LM
    Speroff, T
    Landefeld, CS
    GASTROENTEROLOGY, 1997, 113 (04) : 1278 - 1288
  • [2] Mortality in patients with end-stage liver disease above model for end-stage liver disease 3.0 of 40
    Tarlow, Branden D.
    Kim, W. Ray
    Mannalithara, Ajitha
    Kwo, Paul Y.
    Bonham, C. Andrew
    Kwong, Allison
    HEPATOLOGY, 2023, 77 (03) : 851 - 861
  • [3] Prognostic factors for late mortality after liver transplantation for benign end-stage liver disease
    Zhang Ying-cai
    Zhang Qi
    Li Hua
    Zhang Jian
    Wang Gen-shu
    Xu Chi
    Yi Shu-hong
    Yi Hui-min
    Cai Chang-jie
    Lu Min-qiang
    Yang Yang
    Chen Gui-hua
    CHINESE MEDICAL JOURNAL, 2011, 124 (24) : 4229 - 4235
  • [4] Prognostic factors for late mortality after liver transplantation for benign end-stage liver disease
    ZHANG YingcaiZHANG QiLI HuaZHANG JianWANG GenshuXU ChiYI ShuhongYI Huimin CAI ChangjieLU MinqiangYANG Yang and CHEN Guihua Liver Transplantation CenterThird Affiliated Hospital of Sun Yatsen UniversityGuangzhouGuangdong China Guangdong Provincial Key Laboratory of Liver Disease GuangzhouGuangdong China
    中华医学杂志(英文版), 2011, (24) : 4229 - 4235
  • [5] Clinical Analysis of Factors Affecting Hospital Mortality After Liver Transplant in Patients With High Model for End-Stage Liver Disease Score
    Choi, Ho Joong
    Na, Gun Hyung
    Seo, Chang Ho
    Park, Sung Eun
    Ahn, Joshep
    Hong, Tae Ho
    You, Young Kyoung
    TRANSPLANTATION PROCEEDINGS, 2022, 54 (02) : 424 - 429
  • [6] Factors prognostic of survival in patients awaiting liver transplantation for end-stage liver disease
    Selcuk, Haldun
    Uruc, Irfan
    Temel, Mehtap Akcil
    Ocal, Serkan
    Huddam, Bulent
    Korkmaz, Murat
    Unal, Hakan
    Kanbay, Mehmet
    Savas, Nurten
    Gur, Gurden
    Yilmaz, Ugur
    Haberal, Mehmet
    DIGESTIVE DISEASES AND SCIENCES, 2007, 52 (11) : 3217 - 3223
  • [7] Factors Prognostic of Survival in Patients Awaiting Liver Transplantation for End-Stage Liver Disease
    Haldun Selcuk
    Irfan Uruc
    Mehtap Akcil Temel
    Serkan Ocal
    Bulent Huddam
    Murat Korkmaz
    Hakan Unal
    Mehmet Kanbay
    Nurten Savas
    Gurden Gur
    Ugur Yilmaz
    Mehmet Haberal
    Digestive Diseases and Sciences, 2007, 52 : 3217 - 3223
  • [8] The Model for End-stage Liver Disease Score An Independent Prognostic Factor of Mortality in Injured Cirrhotic Patients
    Inaba, Kenji
    Barmparas, Galinos
    Resnick, Shelby
    Browder, Timothy
    Chan, Linda S.
    Lam, Lydia
    Talving, Peep
    Demetriades, Demetrios
    ARCHIVES OF SURGERY, 2011, 146 (09) : 1074 - 1078
  • [9] Analysis of mortality prognostic factors using model for end-stage liver disease with incorporation of serum-sodium classification for liver cirrhosis complications
    Kim, Yuna
    Kim, Kyunghee
    Jang, Insil
    MEDICINE, 2019, 98 (45) : e17862
  • [10] Kidney function and mortality post-liver transplant in the Model for End-Stage Liver Disease era
    Sethi, Aastha
    Estrella, Michelle M.
    Ugarte, Richard
    Atta, Mohamed G.
    INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE, 2011, 4 : 139 - 144